Company filings profile · CIK 0002058707

Attovia Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Attovia Therapeutics, Inc. (ATTO): 27 filings in the last 90 days vs 1 in the prior 90 (filing-velocity rising ↑ · 27×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Aug 5, 2026. Source-linked, daily-refreshed.

Material 8-K events — Attovia Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
No itemized 8-K in the current window.

Watch Attovia Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Aug 5, 20263
Aug 5, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263

Recent filings

FiledFormDetail
Aug 5, 20263
Aug 5, 20263 FORM 3
Aug 5, 2026424B4 424B4
Aug 4, 2026EFFECT Item ; Item ; Item
Aug 4, 20263 3
Aug 4, 20263 OWNERSHIP DOCUMENT
Aug 4, 20263 3
Aug 4, 20263 FORM 3
Aug 4, 20263 3
Aug 4, 20263
Aug 4, 20263
Aug 4, 20263 3
Aug 4, 20263
Aug 4, 20263 3
Aug 4, 20263
Aug 4, 20263 3
Aug 4, 20263
Aug 4, 20263 3
Aug 4, 20263 FORM 3
Aug 4, 20263
Aug 4, 20263 3
Aug 4, 2026CERT
Aug 4, 2026S-1/A S-1/A
Jul 29, 20268-A12B 8-A12B
Jul 29, 2026S-1/A S-1/A
Jul 14, 2026S-1 S-1
Jun 5, 2026DRS/A
Feb 12, 2026DRS/A
Dec 19, 2025DRS